NCT03010904

Brief Summary

This study aims to investigate differences in digestion rates and gastrointestinal problems caused by pasteurized; pasturized and homogenized as well as UHT-treated homogenized cow's milks in healthy adults by diary of symptoms, blood glucose and triacylglycerol levels and plasma cytokine levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 4, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

1.3 years

First QC Date

January 4, 2017

Last Update Submit

May 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gastrointestinal symptoms (self reported)

    Gastrointestinal symptoms (self-reported) as measured by a questionnaire. The questionnaire is devided into seven types of gastrointestinal discomfort, and also includes a possibility to describe a gastrointestinal discomfort outside these seven given alternatives. The severity of the symptoms is self-reported on a three-step scale.

    day 0 - day 5

Secondary Outcomes (3)

  • Plasma triacylglycerols

    20 min, 40 min, 60 min, 120 min, 180 min, 240 min, 300 min

  • Plasma glucose

    20 min, 40 min, 60 min, 120 min, 180 min, 240 min, 300 min

  • Plasma insulin

    20 min, 40 min, 60 min, 120 min, 180 min, 240 min, 300 min

Study Arms (3)

pasteurized milk

EXPERIMENTAL

milk that has undergone pasteurization treatment

Other: Dietary intervention

homogenized pasteurized milk

EXPERIMENTAL

Milk that has undergone homogenization and pasteurization treatment

Other: Dietary intervention

UHT milk

EXPERIMENTAL

Milk that has undergone homogenization and ultra high temperature treatment

Other: Dietary intervention

Interventions

UHT milkhomogenized pasteurized milkpasteurized milk

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Homogenized and pasteurized milk causes gastrointestinal problems (self-reported) unhomogenized and unpasteurized milk does not cause gastrointestinal problems (self-reported)
  • age 18-65
  • BMI 18,5 - 30
  • hemoglobin under normal range
  • fasting plasma alanine aminotransferase ALAT \< 60 U/l (normal liver function)
  • fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
  • fasting plasma creatinine \< 118 umol/l (normal kidney function)

You may not qualify if:

  • pace maker
  • Crohn's disease or other disease of the intestinal tract
  • intestinal operation within the last 3 months
  • difficult dysphagia
  • smoking
  • constipation
  • lactose intolerance
  • coeliac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Biochemistry, University of Turku

Turku, 20014, Finland

Location

Food Chemistry, Department of Biochemistry, University of Turku

Turku, 20500, Finland

Location

MeSH Terms

Interventions

Diet Therapy

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Kaisa M Linderborg, PhD

    Department of Biochemistry, University of Turku

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 4, 2017

First Posted

January 5, 2017

Study Start

January 1, 2017

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

May 25, 2022

Record last verified: 2022-05

Locations